These observations, together with the autophagy deregulation observed in SMN-reduced cells [15, 16, 46], support the hypothesis that autophagy manipulation may be useful in treating SMA, always keeping in mind the complexity of the autophagy process and avoiding to attribute the results obtained exclusively to autophagy regulation. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.